Kura Oncology, Inc.
KURA
Revenue
0.00
0.000.00%
-Assets
515.12M
▼-38.79M▼-7.00%
3 Months ChangeLiabilities
49.05M
▲222.00k▲0.4547%
3 Months ChangeFree Cash Flow
-48.93M
▼-13.02M▼-36.26%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-17
Form 8-K
ID: 0001193125-24-220529
2024-08-08
Form 10-Q
ID: 0000950170-24-093997
2024-08-08
Form 8-K
ID: 0000950170-24-093945
2024-06-07
Form 8-K
ID: 0000950170-24-070584
2024-05-24
Form 8-K
ID: 0001193125-24-147030
2024-05-02
Form 10-Q
ID: 0000950170-24-052136
2024-05-02
Form 8-K
ID: 0000950170-24-052109
2024-02-27
Form 8-K
ID: 0000950170-24-021087
2024-01-30
Form 8-K
ID: 0001193125-24-018713
2024-01-26
Form 8-K
ID: 0001193125-24-016715